Reviva Pharmaceuticals Holdings, Inc. (RVPH) Stock Analysis & Investment Frameworks
Reviva Pharmaceuticals Holdings, Inc. (RVPH) stock analysis on Invetso. Review Reviva Pharmaceuticals Holdings, Inc.’s key financial metrics, company overview and 10 institutional-grade investment frameworks including SWOT Analysis, Economic Moat, Porter’s Five Forces and the Invetso Quality Score.
Reviva Pharmaceuticals Holdings, Inc. Company Overview
- Exchange: Other OTC
- Sector: Healthcare
- Industry: Biotechnology
- Country: US
Reviva Pharmaceuticals Holdings, Inc. Key Financial Metrics
- Market Cap: $5.82M
- Revenue: $N/A
- ROE: -64.39%
- ROIC: -17.05%
- Dividend Yield: N/A
About Reviva Pharmaceuticals Holdings, Inc.
Reviva Pharmaceuticals Holdings, Inc., a biopharmaceutical company, discovers, develops, and commercializes next-generation therapeutics for diseases targeting unmet medical needs in the areas of central nervous system, respiratory, inflammatory, and cardiometabolic diseases. The company’s lead product candidate comprises brilaroxazine (RP5063) for the treatment of neuropsychiatric indications, such as schizophrenia, bipolar disorder, major depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia and Alzheimer’s disease, and Parkinson’s disease psychosis. It also engages in the clinical development for respiratory indications, such as pulmonary arterial hypertension and idiopathic pulmonary fibrosis. In addition, the company is in preclinical development for the treatment of psoriasis; and RP1208 for the treatment of depression and obesity. The company was founded in 2018 and is headquartered in Cupertino, California.
Reviva Pharmaceuticals Holdings, Inc. Investment Frameworks
Invetso analyzes Reviva Pharmaceuticals Holdings, Inc. (RVPH) across the following frameworks:
- Reviva Pharmaceuticals Holdings, Inc. 10Y Growth Potential
- Reviva Pharmaceuticals Holdings, Inc. Scenario Analysis
- Reviva Pharmaceuticals Holdings, Inc. Risks & Opportunities
- Reviva Pharmaceuticals Holdings, Inc. Economic Moat
- Reviva Pharmaceuticals Holdings, Inc. Business Model
- Reviva Pharmaceuticals Holdings, Inc. Management
- Reviva Pharmaceuticals Holdings, Inc. SWOT Analysis
- Reviva Pharmaceuticals Holdings, Inc. Porter's 5 Forces
- Reviva Pharmaceuticals Holdings, Inc. PESTLE Analysis
- Reviva Pharmaceuticals Holdings, Inc. ESG Analysis